76 related articles for article (PubMed ID: 3781759)
1. Specific impairment of ADP-induced platelet aggregation by cannabinoids.
Nathan I; Dvilansky A; Lazarowitz J; Lander N; Livne A
Int J Tissue React; 1986; 8(3):193-8. PubMed ID: 3781759
[TBL] [Abstract][Full Text] [Related]
2. Impairment of ADP-induced platelet aggregation by hashish components.
Levy R; Schurr A; Nathan I; Dvilanski A; Livne A
Thromb Haemost; 1976 Dec; 36(3):634-40. PubMed ID: 1037158
[TBL] [Abstract][Full Text] [Related]
3. Effects of carbenicillin and phosphomycin on ADP induced platelet aggregation.
Orts A; Martí JL; Castejón J; Baltar I; Esplugues J
Rev Esp Fisiol; 1979 Sep; 35(3):265-8. PubMed ID: 504765
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet aggregation by 5-nitro-2-furaldehyde diacetate with observations on structure-activity relationships.
Rossi EC; Nimer S; Louis G
J Lab Clin Med; 1976 Apr; 87(4):703-9. PubMed ID: 1270881
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom.
Lopez-Johnston JC; de Bosch N; Scannone H; Rodríguez-Acosta A
Ann Hematol; 2007 Dec; 86(12):879-85. PubMed ID: 17891398
[TBL] [Abstract][Full Text] [Related]
6. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
[TBL] [Abstract][Full Text] [Related]
7. Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.
Michal F; Motamed M
Br J Pharmacol; 1975 Jun; 54(2):221P-222P. PubMed ID: 1148513
[No Abstract] [Full Text] [Related]
8. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood.
Glenn JR; White AE; Johnson A; Fox SC; Behan MW; Dolan G; Heptinstall S
Platelets; 2005; 16(3-4):159-70. PubMed ID: 16011960
[TBL] [Abstract][Full Text] [Related]
9. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Pampuch A; Cerletti C; de Gaetano G
Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
Yang J; Hua WY; Wang FX; Wang ZY; Wang X
Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
[TBL] [Abstract][Full Text] [Related]
11. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
Peerschke EI; Galanakis DK
J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
[TBL] [Abstract][Full Text] [Related]
12. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis.
Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S
Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939
[TBL] [Abstract][Full Text] [Related]
13. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
[TBL] [Abstract][Full Text] [Related]
14. The ability of poloxamers to inhibit platelet aggregation depends on their physicochemical properties.
Ahmed F; Alexandridis P; Shankaran H; Neelamegham S
Thromb Haemost; 2001 Dec; 86(6):1532-9. PubMed ID: 11776324
[TBL] [Abstract][Full Text] [Related]
15. Deaggregation is an integral component of the response of platelets to ADP in vitro: kinetic studies of literature and original data.
Maayani S; Tagliente TM; Schwarz T; Craddock-Royal B; Alcala C; Marrero G; Martinez R
Platelets; 2001 Aug; 12(5):279-91. PubMed ID: 11487380
[TBL] [Abstract][Full Text] [Related]
16. Role of intracellular signaling events in ADP-induced platelet aggregation.
Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
[TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation.
Losonczy H; Nagy I; Gregus Z
Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713
[No Abstract] [Full Text] [Related]
19. Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregation.
Windscheif U; Radziwon P; Breddin HK; Bäumert HG; Lambrecht G; Mutschler E
Arzneimittelforschung; 1995 Sep; 45(9):994-7. PubMed ID: 7488321
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin modulates platelet activation in vitro through protein-tyrosine phosphorylation.
Kubota Y; Arai T; Tanaka T; Yamaoka G; Kiuchi H; Kajikawa T; Kawanishi K; Ohnishi H; Yamaguchi M; Takahara J; Irino S
Stem Cells; 1996 Jul; 14(4):439-44. PubMed ID: 8843545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
